Loading...
Header Logo
Keywords
Last Name
Institution
 Back to Profile

Stephanie Carreiro

Concepts (70)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fat Emulsions, Intravenous
4
2015
31
2.000
 Why?
Cocaine
4
2015
67
1.590
 Why?
Substance Abuse Detection
2
2015
26
1.370
 Why?
Monitoring, Ambulatory
2
2015
54
1.320
 Why?
Substance-Related Disorders
2
2015
374
0.960
 Why?
Biosensing Techniques
2
2017
71
0.810
 Why?
Hemodynamics
2
2013
168
0.720
 Why?
Cocaine-Related Disorders
1
2015
54
0.680
 Why?
Disease Models, Animal
3
2013
1202
0.640
 Why?
Advanced Cardiac Life Support
1
2013
7
0.620
 Why?
Vasoconstrictor Agents
1
2013
28
0.610
 Why?
Epinephrine
1
2013
46
0.610
 Why?
Skin
1
2015
231
0.590
 Why?
Galvanic Skin Response
2
2015
20
0.350
 Why?
Rats, Sprague-Dawley
4
2013
485
0.350
 Why?
Analgesics, Opioid
2
2017
166
0.320
 Why?
Random Allocation
2
2013
164
0.300
 Why?
Rats
4
2013
1781
0.290
 Why?
Heart Rate
2
2013
219
0.280
 Why?
Male
8
2017
17006
0.280
 Why?
Blood Pressure
2
2013
359
0.270
 Why?
Reproducibility of Results
2
2015
986
0.260
 Why?
Pilot Projects
3
2017
488
0.230
 Why?
Medical Informatics Applications
1
2017
14
0.210
 Why?
Oxycodone
1
2017
15
0.210
 Why?
Fractures, Bone
1
2017
113
0.190
 Why?
Medication Adherence
1
2017
133
0.180
 Why?
Skin Temperature
1
2015
13
0.180
 Why?
Motion
1
2015
32
0.180
 Why?
Animals
5
2015
14887
0.180
 Why?
Wrist
1
2015
17
0.170
 Why?
Body Temperature
1
2015
46
0.170
 Why?
Dose-Response Relationship, Drug
2
2013
697
0.170
 Why?
Feasibility Studies
1
2015
253
0.160
 Why?
beta-Alanine
1
2013
7
0.160
 Why?
Antithrombins
1
2013
8
0.160
 Why?
Atropine
1
2013
12
0.160
 Why?
Muscarinic Antagonists
1
2013
16
0.160
 Why?
Adult
3
2017
9524
0.150
 Why?
Sodium Chloride
1
2013
42
0.150
 Why?
Benzimidazoles
1
2013
20
0.150
 Why?
Middle Aged
3
2017
9740
0.150
 Why?
Blood Coagulation
1
2013
33
0.150
 Why?
Parenteral Nutrition, Total
1
2013
20
0.150
 Why?
Electrocardiography
1
2013
292
0.140
 Why?
Hemorrhage
1
2013
156
0.140
 Why?
Survival Rate
1
2013
470
0.140
 Why?
Cyclohexylamines
1
2012
5
0.140
 Why?
Salvia
1
2012
4
0.140
 Why?
Alkaloids
1
2012
13
0.140
 Why?
Patient Acceptance of Health Care
1
2015
247
0.140
 Why?
Cyclohexanones
1
2012
7
0.140
 Why?
Mitragyna
1
2012
8
0.140
 Why?
Cannabinoids
1
2012
27
0.140
 Why?
Psychotropic Drugs
1
2012
56
0.130
 Why?
Kinetics
1
2013
715
0.130
 Why?
Piperazines
1
2012
96
0.130
 Why?
Massachusetts
1
2015
1510
0.120
 Why?
Female
3
2017
18511
0.110
 Why?
Aged, 80 and over
1
2015
2813
0.100
 Why?
Time Factors
1
2013
2591
0.100
 Why?
Aged
2
2017
7519
0.090
 Why?
Humans
4
2017
33661
0.090
 Why?
Capsules
1
2017
22
0.050
 Why?
Bleeding Time
1
2013
7
0.040
 Why?
Cholinergic Antagonists
1
2013
25
0.040
 Why?
Emergency Service, Hospital
1
2017
356
0.040
 Why?
Infusions, Intravenous
1
2013
138
0.040
 Why?
Administration, Oral
1
2013
201
0.040
 Why?
Young Adult
1
2017
2073
0.030
 Why?
Carreiro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (70) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_